'Pharma bro' Martin Shkreli ordered to pay $64m. to price gouging victims
The FTC and seven states, including New York, sued in January 2020 accusing Vyera Pharmaceuticals — formerly Shkreli’s company Turing — of increasing the price of Daraprim by more than 4,000%.
Former drug company executive Martin Shkreli arrives at US District Court for the fourth day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York City, US, August 3, 2017.(photo credit: REUTERS/AMR ALFIKY)ByELIZABETH KEOGH/NEW YORK DAILY NEWS/TNSUpdated: